| Income Statement |
| Total Revenue | 925.00M |
|
| Revenues (USD) | 925.00M |
| Cost of Revenue | 197.00M |
| Gross Profit | 728.00M |
| Operating Expenses | 652.00M |
| Research and Development Expense | 107.00M |
| Selling, General and Administrative Expense | 509.00M |
| Operating Income | 76.00M |
| Interest Expense | 2.00M |
| Income Tax Expense | 19.00M |
| Net Income | 55.00M |
| Net Income Common Stock | 55.00M |
| Net Income Common Stock (USD) | 55.00M |
| Consolidated Income | 55.00M |
| Earnings per Basic Share | 0.14 |
| Earnings per Basic Share (USD) | 0.14 |
| Earnings per Diluted Share | 0.14 |
| Earning Before Interest & Taxes (EBIT) | 76.00M |
| Earning Before Interest & Taxes (USD) | 76.00M |
| Weighted Average Shares | 404.10M |
| Weighted Average Shares Diluted | 404.40M |
| Balance Sheet |
| Cash and Equivalents | 1.27B |
| Cash and Equivalents (USD) | 1.27B |
| Trade and Non-Trade Receivables | 253.00M |
| Current Assets | 1.65B |
| Property, Plant & Equipment Net | 1.57B |
| Total Assets | 10.14B |
| Debt Current | 30.00M |
| Total Debt | 1.20B |
| Current Liabilities | 747.00M |
| Debt Non-Current | 1.17B |
| Total Liabilities | 2.19B |
| Shareholders Equity | 7.93B |
| Shareholders Equity (USD) | 7.93B |
| Assets Non-Current | 8.49B |
| Total Debt (USD) | 1.20B |
| Deferred Revenue | 233.00M |
| Goodwill and Intangible Assets | 6.65B |
| Liabilities Non-Current | 1.45B |
| Trade and Non-Trade Payables | 454.00M |
| Tax Assets | 41.00M |
| Tax Liabilities | 275.00M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 92.00M |
| Net Cash Flow from Financing | -108.00M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -50.00M |
| Capital Expenditure | -58.00M |
| Issuance (Purchase) of Equity Shares | -80.00M |
| Net Cash Flow from Investing | -56.00M |
| Net Cash Flow - Investment Acquisitions and Disposals | 2.00M |
| Net Cash Flow from Operations | 115.00M |
| Effect of Exchange Rate Changes on Cash | -1000.00K |
| Share Based Compensation | 38.00M |